NIH – MPP, COVID-19 Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement
Boston University Startup Exclusive License Template Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingBoston University Startup Exclusive License Template
Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement Post author:GHIAA Admin Post published:May 31, 2022 Post category: Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 23, 2022 Post category: Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement
BMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingBMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement
Cellscript – BioNTech mRNA Technology Patent Sublicense Post author:GHIAA Admin Post published:March 17, 2022 Post category: Continue ReadingCellscript – BioNTech mRNA Technology Patent Sublicense
Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement Post author:GHIAA Admin Post published:March 3, 2022 Post category: Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement
Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:February 2, 2022 Post category: Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement
CEPI – Dynavax, COVID-19 Material Reservation Agreement Post author:GHIAA Admin Post published:January 31, 2022 Post category: Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement